摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Z-β2-HLys(Boc)-OH | 1027602-36-3

中文名称
——
中文别名
——
英文名称
Z-β2-HLys(Boc)-OH
英文别名
(S)-6-{[(tert-butoxy)carbonyl]amino}-2-{[(benzyloxycarbonyl)amino]methyl}-hexanoyl acid;(S)-2-[(benzyloxycarbonylamino)methyl]-6-(tert-butoxycarbonylamino)hexanoic acid;(2S)-6-[(2-methylpropan-2-yl)oxycarbonylamino]-2-(phenylmethoxycarbonylaminomethyl)hexanoic acid
Z-β<sup>2</sup>-HLys(Boc)-OH化学式
CAS
1027602-36-3
化学式
C20H30N2O6
mdl
——
分子量
394.468
InChiKey
HBQLIKRBEZTXQM-INIZCTEOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    599.0±50.0 °C(Predicted)
  • 密度:
    1.160±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    28
  • 可旋转键数:
    13
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    114
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Z-β2-HLys(Boc)-OH三异丙基硅烷四丁基氟化铵三氟乙酸 作用下, 以 为溶剂, 生成 (R)-3-hydroxybutyryl-(S)-β2-HLys-(S)-β3-HTrp-2-phenylethylamide
    参考文献:
    名称:
    β2/β3-di- and α/β3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors
    摘要:
    Four linear beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptides (1-4) were investigated as somatostatin sst(4) receptor agonists on recombinant human and mouse somatostatin receptors. Human somatostatin receptor subtypes 1-5 (sst(1-5)), and mouse somatostatin receptor subtypes 1,3,4 and 5, were characterised using the agonist radioligands [I-125]LTT-SRIF-28, [I-125][Tyr(10)]CST14 and [I-125]CGP 23996 in stably transfected Chinese hamster lung fibroblast (CCL39) cells. The peptides bound selectively to sst4 receptors with nanomolar affinity (pK(d)=5.4-7.8). The peptides were investigated on second messenger systems both as agonists, and as antagonists to SRIF-14-mediated effects in CCL39 cells expressing mouse sst(4) receptors, via measurement of inhibition of forskolin-stimulated adenylate cyclase activity, and stimulation of luciferase expression. The peptides showed full agonism or pronounced partial agonism (40 to 100% relative intrinsic activity) in both inhibition of forskolin-stimulated adenylate cyclase activity (pEC(50)=5.5-6.8), and luciferase expression (pEC(50)=5.5-6.5). The agonist potential was confirmed since antagonism was very difficult to establish. The data show that beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives have agonist potential at recombinant somatostatin sst(4) receptors. Therefore, they may be used to elucidate physiological and biochemical effects mediated by sst(4), and may also have potential as therapeutic agents.
    DOI:
    10.1007/s00210-002-0673-4
  • 作为产物:
    描述:
    叔丁氧羰酰基6-氨基己酸 在 lithium hydroxide monohydrate 、 叠氮磷酸二苯酯 、 palladium 10% on activated carbon 、 氢气双氧水三乙胺lithium chloridelithium hexamethyldisilazane 作用下, 以 四氢呋喃乙酸乙酯 为溶剂, -78.0~20.0 ℃ 、101.33 kPa 条件下, 反应 53.5h, 生成 Z-β2-HLys(Boc)-OH
    参考文献:
    名称:
    反式六氢苯并恶唑烷酮在含有蛋白质侧链的 β2-氨基酸的对映选择性合成中
    摘要:
    描述了使用对映体纯反式六氢苯并恶唑烷酮作为手性助剂在两种对映体形式中含有蛋白质侧链(β2-h苯丙氨酸和β2-h赖氨酸)的两种β2-氨基酸的对映选择性合成。基于 X 射线衍射分析和化学关联方法分配绝对构型。
    DOI:
    10.1002/ejoc.201301834
点击查看最新优质反应信息

文献信息

  • Peptide Folding Induces High and Selective Affinity of a Linear and Small β-Peptide to the Human Somatostatin Receptor 4
    作者:Karl Gademann、Thierry Kimmerlin、Daniel Hoyer、Dieter Seebach
    DOI:10.1021/jm010816q
    日期:2001.7.1
    analysis, Figure 2) and there is high and specific nanomolar affinity for hsst(4) receptor (Table 1). In contrast, the isomer 2 bearing the Lys side chain in 3-, rather than in the 2-position, has a 1000-fold smaller affinity to hsst(4). The syntheses of the required Fmoc-protected beta-amino acids (8-11, 17) are described (Schemes 1-3). Coupling of the beta-amino acids was achieved by the manual solid-phase
    已知相邻残基(具有(S)构型)的2和3位侧链的β肽会折叠并形成一个转角(类似于α肽β转角)。因此,我们合成了适当取代的β-四肽衍生物,以模拟生长激素抑制素与人类受体hsst(1-5)的结合,后者已知会在含有氨基酸残基Thr,Lys,Trp,和Phe。N-乙酰基肽酰胺Ac-beta(3)-HThr-beta(2)-HLys-beta(3)-HTrp-beta(3)-HPhe-NH(2)(1)确实显示了有针对性的拟态模拟:Lys CH(2)基团位于Trp吲哚环的屏蔽锥中(通过NMR分析,图2),并且对hsst(4)受体具有很高的纳摩尔亲和力(表1)。相比之下,带有Lys侧链的异构体2位于3-位,而不是位于2位,与hsst(4)的亲和力小1000倍。描述了所需的Fmoc保护的β-氨基酸(8-11、17)的合成(方案1-3)。β-氨基酸的偶联是通过手动固相技术在Rink树脂上完成的。
  • β2/β3-di- and α/β3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors
    作者:Caroline Nunn、Magnus Rueping、Daniel Langenegger、Edi Schuepbach、Thierry Kimmerlin、Peter Micuch、Konstanze Hurth、Dieter Seebach、Daniel Hoyer
    DOI:10.1007/s00210-002-0673-4
    日期:2003.2
    Four linear beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptides (1-4) were investigated as somatostatin sst(4) receptor agonists on recombinant human and mouse somatostatin receptors. Human somatostatin receptor subtypes 1-5 (sst(1-5)), and mouse somatostatin receptor subtypes 1,3,4 and 5, were characterised using the agonist radioligands [I-125]LTT-SRIF-28, [I-125][Tyr(10)]CST14 and [I-125]CGP 23996 in stably transfected Chinese hamster lung fibroblast (CCL39) cells. The peptides bound selectively to sst4 receptors with nanomolar affinity (pK(d)=5.4-7.8). The peptides were investigated on second messenger systems both as agonists, and as antagonists to SRIF-14-mediated effects in CCL39 cells expressing mouse sst(4) receptors, via measurement of inhibition of forskolin-stimulated adenylate cyclase activity, and stimulation of luciferase expression. The peptides showed full agonism or pronounced partial agonism (40 to 100% relative intrinsic activity) in both inhibition of forskolin-stimulated adenylate cyclase activity (pEC(50)=5.5-6.8), and luciferase expression (pEC(50)=5.5-6.5). The agonist potential was confirmed since antagonism was very difficult to establish. The data show that beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives have agonist potential at recombinant somatostatin sst(4) receptors. Therefore, they may be used to elucidate physiological and biochemical effects mediated by sst(4), and may also have potential as therapeutic agents.
  • <i>trans</i>-Hexahydrobenzoxazolidinones in the Enantioselective Synthesis of β<sup>2</sup>-Amino Acids Containing Proteinogenic Side Chains
    作者:Yamir Bandala、Gloria Reyes-Rangel、Arturo Obregón-Zúñiga、Carlos Cruz-Hernández、Gerardo Corzo、Eusebio Juaristi
    DOI:10.1002/ejoc.201301834
    日期:2014.4
    The use of enantiopure trans-hexahydrobenzoxazolidinones as chiral auxiliaries in the enantioselective synthesis of two β2-amino acids containing proteinogenic side chains (β2-hPhenylalanine and β2-hLysine), in both enantiomeric forms, is described. Absolute configurations were assigned on the basis of X-ray diffraction analysis and chemical correlation methods.
    描述了使用对映体纯反式六氢苯并恶唑烷酮作为手性助剂在两种对映体形式中含有蛋白质侧链(β2-h苯丙氨酸和β2-h赖氨酸)的两种β2-氨基酸的对映选择性合成。基于 X 射线衍射分析和化学关联方法分配绝对构型。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐